Walbert Keli (CIK 2051489) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-14). Recent activity: Sell APLS (17,051 shares), Sell APLS (8,332 shares), Sell APLS (664 shares), Sell APLS (7,297 shares), Buy APLS (7,961 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 17,051 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 8,332 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 664 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 7,297 | $0 |
| 2026-01-05 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Buy | 7,961 | $0 |
Source: SEC Form 4 filings · as of 2026-05-14